Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

9.1K
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
9.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

8.8K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.8K
What is the Immune System?01:38

What is the Immune System?

127.1K
Overview
127.1K
What are Viruses?00:50

What are Viruses?

127.9K
Overview
127.9K
Humoral Immune Responses01:36

Humoral Immune Responses

83.5K
Overview
83.5K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver Organoids.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Epidemic features and potential impact of vaccine campaigns on the 2025 chikungunya outbreak in southern China: a mathematical modelling study.

New microbes and new infections·2026
Same author

The guanosine nucleotide analog bemnifosbuvir inhibits hepatitis E virus infection in cell and organoid models.

Virologica Sinica·2026
Same author

Current and Future Landscape of Hepatocellular Carcinoma Treatment.

Oncology research·2026
Same author

Standardizing antiviral response metrics for mono- and combination therapies in acute, chronic and latent viral infections.

Virology journal·2026
Same author

Host mature tRNAome as a decoding switch regulates antiviral and proviral responses.

Nature communications·2026

Related Experiment Video

Updated: Jan 23, 2026

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection
07:36

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection

Published on: February 28, 2021

3.4K

The Interplay between Host Innate Immunity and Hepatitis E Virus.

Yang Li1,2, Changbo Qu3, Peifa Yu4

  • 1China-Malaysia National Joint Laboratory, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, China. y.li.2@erasmusmc.nl.

Viruses
|June 20, 2019
PubMed
Summary

Hepatitis E virus (HEV) infection triggers a complex innate immune response. Understanding how HEV evades immunity is key to developing new antiviral therapies for this emerging global health issue.

Keywords:
Hepatitis E virusInflammationInnate immunityInterferon

More Related Videos

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.9K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Related Experiment Videos

Last Updated: Jan 23, 2026

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection
07:36

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection

Published on: February 28, 2021

3.4K
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.9K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis E virus (HEV) infection is an emerging global health concern with variable clinical outcomes.
  • The host innate immune system is crucial for defense against HEV, but its dysregulation can lead to severe disease.
  • Both experimental models and patients show an active innate immune response to HEV infection.

Purpose of the Study:

  • To comprehensively review the host innate immune response during HEV infection.
  • To elucidate HEV's strategies for evading immune responses.
  • To explore the implications for understanding pathogenesis and developing antiviral therapies.

Main Methods:

  • Review of existing literature on HEV-innate immunity interactions.
  • Analysis of pathogen recognition pathways.
  • Examination of interferon and inflammatory responses.
  • Investigation of innate immune cell involvement.

Main Results:

  • HEV infection elicits a robust innate immune response involving pathogen recognition, interferon signaling, and inflammation.
  • HEV employs sophisticated mechanisms to counteract and evade the host innate immune system.
  • Specific innate immune cells play critical roles in controlling or exacerbating HEV infection.

Conclusions:

  • Dysregulation of the innate immune response contributes to severe HEV pathogenesis.
  • Deciphering these intricate interactions is vital for advancing HEV treatment strategies.
  • Targeting innate immunity pathways may offer novel therapeutic avenues against HEV.